|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holohan C, Van Schaeybroeck S, Longley DB
and Johnston PG: Cancer drug resistance: An evolving paradigm. Nat
Rev Cancer. 13:714–726. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zahreddine H and Borden KL: Mechanisms and
insights into drug resistance in cancer. Front Pharmacol. 4:282013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang F, Zhang W, Guo L, Bao W, Jin N, Liu
R, Liu P, Wang Y, Guo Q and Chen B: Gambogic acid suppresses
hypoxia-induced hypoxia-inducible factor-1a/vascular endothelial
growth factor expression via inhibiting phosphatidylinositol
3-kinase/Akt/mammalian target protein of rapamycin pathway in
multiple myeloma cells. Cancer Sci. 105:1063–1070. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Suzuki R, Kang Y, Li X, Roife D, Zhang R
and Fleming JB: Genistein potentiates the antitumor effect of
5-Fluorouracil by inducing apoptosis and autophagy in human
pancreatic cancer cells. Anticancer Res. 34:4685–4692.
2014.PubMed/NCBI
|
|
6
|
Qi Q, Lu N, Wang XT, Gu HY, Yang Y, Liu W,
Li C, You QD and Guo QL: Anti-invasive effect of gambogic acid in
MDA-MB-231 human breast carcinoma cells. Biochem Cell Biol.
86:386–395. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Qi Q, Lu N, Dai Q, Li F, Wang X, You
Q and Guo Q: Gambogic acid promotes apoptosis and resistance to
metastatic potential in MDA-MB-231 human breast carcinoma cells.
Biochem Cell Biol. 90:718–730. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li D, Song XY, Yue QX, Cui YJ, Liu M, Feng
LX, Wu WY, Jiang BH, Yang M, Qu XB, et al: Proteomic and
bioinformatic analyses of possible target-related proteins of
gambogic acid in human breast carcinoma MDA-MB-231 cells. Chin J
Nat Med. 13:41–51. 2015.PubMed/NCBI
|
|
9
|
Wang S, Wang L, Chen M and Wang Y:
Gambogic acid sensitizes resistant breast cancer cells to
doxorubicin through inhibiting P-glycoprotein and suppressing
survivin expression. Chem Biol Interact. 235:76–84. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Deng R, Lu Y, Xu Q, Yan M, Ye D
and Chen W: Gambogic acid as a non-competitive inhibitor of
ATP-binding cassette transporter B1 reverses the multidrug
resistance of human epithelial cancers by promoting ATP-binding
cassette transporter B1 protein degradation. Basic Clin Pharmacol
Toxicol. 112:25–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J and Yuan Z: Gambogic acid
sensitizes ovarian cancer cells to doxorubicin through ROS-mediated
apoptosis. Cell Biochem Biophys. 67:199–206. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Zhou H, Yu Y, Li J, Li H, Jiang
D, Chen Z, Yang D, Xu Z and Yu Z: Combination of gambogic acid with
cisplatin enhances the antitumor effects on cisplatin-resistant
lung cancer cells by downregulating MRP2 and LRP expression. Onco
Targets Ther. 9:3359–3368. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W,
Zhao H, Zhao L, Jiang Q, Yu Z, et al: The hedgehog signalling
pathway mediates drug response of MCF-7 mammosphere cells in breast
cancer patients. Clin Sci. 129:809–822. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chi Y, Zhan XK, Yu H, Xie GR, Wang ZZ,
Xiao W, Wang YG, Xiong FX, Hu JF, Yang L, et al: An open-labeled,
randomized, multicenter phase IIa study of gambogic acid injection
for advanced malignant tumors. Chin Med J (Engl). 126:1642–1646.
2013.PubMed/NCBI
|
|
16
|
Huang GM, Sun Y, Ge X, Wan X and Li CB:
Gambogic acid induces apoptosis and inhibits colorectal tumor
growth via mitochondrial pathways. World J Gastroenterol.
21:6194–6205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Y, Sun X, Yang Y, Yang X, Zhu H, Dai
S, Chen X, Zhang H, Guo Q, Song Y, et al: Gambogic acid enhances
the radiosensitivity of human esophageal cancer cells by inducing
reactive oxygen species via targeting Akt/mTOR pathway. Tumour
Biol. 37:1853–1862. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rimkus TK, Carpenter RL, Qasem S, Chan M
and Lo HW: Targeting the sonic hedgehog signaling pathway: Review
of smoothened and GLI inhibitors. Cancers. 8(pii): E222016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Noble P, Vyas M, Al-Attar A, Durrant S,
Scholefield J and Durrant L: High levels of cleaved caspase-3 in
colorectal tumour stroma predict good survival. Br J Cancer.
108:2097–2105. 2013. View Article : Google Scholar : PubMed/NCBI
|
